Related Experiment Video
Updated: Mar 7, 2026

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases
Published on: June 20, 2025
Glutathione system participation in thoracic aneurysms from patients with Marfan syndrome
Alejandra María Zúñiga-Muñoz1, Israel Pérez-Torres1, Verónica Guarner-Lans2
12 Pathology, Instituto Nacional de Cardiología Ignacio Chávez, México City, México.
Background:
Aortic dilatation in Marfan syndrome (MFS) is progressive. It is associated with oxidative stress and endothelial dysfunction that contribute to the early acute dissection of the vessel and can result in rupture of the aorta and sudden death. We evaluated the participation of the glutathione (GSH) system, which could be involved in the mechanisms that promote the formation and progression of the aortic aneurysms in MFS patients.
Patients And Methods:
Aortic aneurysm tissue was obtained during chest surgery from eight control subjects and 14 MFS patients. Spectrophotometrical determination of activity of glutathione peroxidase (GPx), glutathione-S-transferase (GST), glutathione reductase (GR), lipid peroxidation (LPO) index, carbonylation, total antioxidant capacity (TAC), and concentration of reduced and oxidized glutathione (GSH and GSSG respectively), was performed in the homogenate from aortic aneurysm tissue.
Results:
LPO index, carbonylation, TGF-β1, and GR activity were increased in MFS patients (p < 0.04), while TAC, GSH/GSSG ratio, GPx, and GST activity were significantly decreased (p < 0.04).
Conclusions:
The depletion of GSH, in spite of the elevated activity of GR, not only diminished the activity of GSH-depend GST and GPx, but increased LPO, carbonylation and decreased TAC. These changes could promote the structural and functional alterations in the thoracic aorta of MFS patients.
Insights
Marfan syndrome (MFS) patients show altered glutathione (GSH) system function, with decreased GSH and related enzyme activity. These changes contribute to aortic aneurysm progression and oxidative stress in MFS.
Area of Science:
- Biochemistry
- Cardiovascular Biology
- Genetics
Background:
- Marfan syndrome (MFS) is characterized by progressive aortic dilatation, linked to oxidative stress and endothelial dysfunction.
- These vascular changes increase the risk of aortic dissection, rupture, and sudden death in MFS patients.
Purpose of the Study:
- To investigate the role of the glutathione (GSH) system in the development and progression of aortic aneurysms in Marfan syndrome.
- To assess specific enzyme activities and oxidative stress markers within aortic tissue of MFS patients.
Main Methods:
- Aortic aneurysm tissue samples were collected from 14 MFS patients and 8 control subjects during surgery.
- Spectrophotometric assays were used to measure the activity of glutathione peroxidase (GPx), glutathione-S-transferase (GST), and glutathione reductase (GR).
- Levels of lipid peroxidation (LPO) index, carbonylation, total antioxidant capacity (TAC), and reduced/oxidized glutathione (GSH/GSSG) were quantified.
Main Results:
- MFS patients exhibited elevated LPO index, carbonylation, and GR activity compared to controls (p < 0.04).
- Significantly decreased TAC, GSH/GSSG ratio, GPx, and GST activity were observed in MFS patients (p < 0.04).
Conclusions:
- The observed depletion of GSH, despite increased GR activity, impaired the function of GSH-dependent enzymes (GST, GPx).
- These biochemical alterations, including increased LPO and carbonylation and reduced TAC, likely contribute to the structural and functional deterioration of the aorta in Marfan syndrome.
Related Concept Videos
Aneurysm I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Aneurysm III: Interprofessional Care
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Thoracic Aorta

